Drug test types compared: urine, blood, saliva, hair

TL;DR

• Urine (THC-COOH): most common screening test, window of days to weeks.
• Blood (Delta-9-THC): the only legally decisive method for driving unfitness (1.5 µg/L).
• Saliva: standard at roadside controls, catches active use in the last few hours.
• Hair: proves long-term use over 3–6 months – common for license reissue.

Urine test – the classic screening

The urine test measures the inactive metabolite THC-COOH, with a standard cutoff of 50 ng/mL (screening) and 15 ng/mL (confirmation via GC-MS). It says nothing about current impairment – only that THC was in the body over the last days (occasional) or weeks (heavy use).

Typical uses: traffic-medicine assessment, license-reissue screening, some workplace contexts. It is not enough to establish driving unfitness in Switzerland – a blood draw always follows.

Blood test – the legally decisive proof

Only the blood test measures active Delta-9-THC and establishes driving unfitness in Switzerland from 1.5 µg/L (VRV Art. 2). It follows a positive saliva screen, taken by police/doctor and analysed in a forensic institute.

Window: 4–8 hours for occasional users, 24–48+ hours for daily users. The blood test is the sole legal basis for fines and license loss.

Saliva and hair tests

• Saliva test: first choice at roadside checks. Cutoff varies (25–50 ng/mL), window typically 4–12 hours. A positive result triggers a blood draw.
• Hair test: covers up to 3 cm (~3 months), up to 6 months for long-term questions. Central to license reissue – proves abstinence or relapse.
• Sweat/patch test: rarely used, mainly in supervised abstinence programmes.

Swiss practice: screening, confirmation and who may order which test

Every drug test in Switzerland has two stages. Stage one is an immunochemical screen (urine, saliva or a roadside rapid test) that only returns a preliminary positive or negative and proves nothing legally. Stage two is a confirmation analysis by GC-MS or LC-MS/MS in a lab accredited to ISO/IEC 17025 – usually an institute of forensic medicine. Only that second value stands up in court, and only it reliably separates THC-COOH from past use from active delta-9-THC.

Who may order a test depends on the context: in road traffic the police act under Art. 55 SVG and can order a preliminary test and a blood draw; employers may only process data necessary for job fitness under Art. 328b CO, which makes suspicionless blanket testing in non-safety-critical roles questionable or unlawful. Medical driving-fitness assessments run through the cantonal road traffic office and frequently use hair analysis covering several months.

• Screen = suspicion, confirmation = proof: a positive rapid test alone justifies neither dismissal nor conviction.
• Urine measures THC-COOH (metabolite, days to weeks); blood and saliva measure active THC (hours).
• Hair analysis covers roughly 1 cm per month and is mainly used in driving-fitness assessments.
• For any positive result, ask for the analytical method and the laboratory's cut-off value.

Sources of error and detection of tampering in the laboratory

Rapid tests are based on immunochemical reactions that are susceptible to interfering factors. Certain medications, including common painkillers or anti-inflammatory drugs, can lead to false-positive results due to structural similarities (cross-reactivity). So-called passive consumption is also frequently used as an excuse. However, scientific studies show that passively absorbed THC is under normal conditions hardly sufficient to exceed the established limit values in urine or blood. Swiss laboratories reliably detect such discrepancies through the mandatory confirmatory analysis.

Attempts to manipulate urine tests by adding foreign substances, extreme fluid intake, or synthetic urine usually fail quickly in Swiss practice. The institutes of forensic medicine routinely test physical and chemical parameters of the sample. These include the temperature immediately after delivery, the pH value, the specific gravity, and the creatinine content. If these values lie outside the physiological norm, the sample is considered adulterated or invalid. Within the framework of abstinence monitoring, this usually has the same legal consequences as a positive result.

• Cross-reactivities due to structurally similar medications in the preliminary test
• Passive consumption almost never leads to limits being exceeded in practice
• Routine measurement of creatinine, pH, and temperature in the laboratory
• Adulterated samples are legally treated as a positive detection

The issue of CBD and legal hemp during checks

Since the liberalisation of cannabis with a total THC content of less than one percent, the consumption of CBD products has been legal and widespread in Switzerland. However, for consumers, this poses significant risks in road traffic and during drug tests. Since legal hemp also contains small amounts of THC and its precursor THCA, regular or high-dose consumption of CBD flowers can lead to accumulation in the body. This regularly leads to positive results in rapid urine and saliva tests, as these cannot differentiate between legal and illegal consumption.

The greatest risk lies in the strict Swiss limit value for road traffic. Since driving incapacity is assumed from a detection level of as little as 1.5 micrograms of THC per litre of blood, the consumption of supposedly legal CBD weed can lead to the revocation of the driving licence. Anyone who regularly smokes Swiss CBD products risks exceeding this extremely low blood limit without feeling any intoxicating effect. Courts and authorities make no distinction here regarding the source of the active ingredient.

• Legal Swiss hemp (under 1% THC) contains measurable traces of THC
• Rapid tests do not differentiate between legal CBD and illegal cannabis
• The blood limit of 1.5 µg/L can also be exceeded through pure CBD consumption
• No legal privileges in the event of driving incapacity caused by legally purchased CBD

Procedure and requirements of hair analysis for abstinence control

Hair analysis is the standard tool used by Swiss road traffic offices to prove stable and long-term cannabis abstinence as part of a traffic medicine assessment. For the test, a pencil-thick strand of hair is usually taken directly from the back of the head. Since hair grows on average about one centimetre per month, a three-centimetre hair segment allows for a seamless analysis of a period of around three months. Cosmetic treatments such as bleaching, dyeing or chemical straightening can alter the structure of the hair and make detection more difficult, which is why such manipulations are noted in the laboratory report.

The administrative and financial burden for those affected is substantial. The costs for sample collection and the subsequent forensic analysis at an institute of forensic medicine must be borne entirely by the individual. In addition, the authorities often require multiple analyses at defined intervals to prove a permanent change in behaviour. If the scalp hair is too short for the required analysis due to baldness or a short haircut, body hair such as chest or armpit hair can be used as an alternative, provided it shows sufficient growth. Otherwise, closely monitored urine tests under direct supervision must be carried out.

• Detection window of approximately one month per centimetre of hair length
• Hair sample collection is carried out directly at the back of the head by trained personnel
• Cosmetic hair treatments must be disclosed to the laboratory
• High out-of-pocket costs for analyses and traffic medicine assessments
• Body hair or urine tests as an alternative in the event of insufficient hair

Legal limits of drug testing in Swiss employment law

In Swiss employment law, the protection of the employee's personality is anchored in the Code of Obligations. This means that employers are not permitted to order systematic drug tests without further ado. A legitimate interest generally only exists for safety-sensitive roles where impairment by substances poses an immediate danger to the business, colleagues or third parties. Typical examples of this are train drivers, professional drivers, crane operators or medical staff. Even in these sectors, the tests must be proportionate and clearly regulated in the employment contract or in a company agreement.

In the event of a justified suspicion of acute impairment during working hours, the employer may intervene in order to fulfil their duty of care and prevent accidents. However, a positive rapid test alone is usually not sufficient for termination without notice, as it does not allow any conclusion to be drawn about the actual incapacity to work at the moment of the test. If an employee in a safety-critical position refuses a justified test, this can, however, lead to consequences under employment law, up to and including ordinary termination. The involvement of the occupational physician is highly recommended in such cases.

• Protection of personality severely restricts drug testing without cause in the workplace
• Admissibility primarily for safety-critical occupations and concrete suspicion
• A positive rapid test does not prove acute incapacity for work
• Refusal of a justified test can have consequences under employment law

FAQ